About the Journal

Jurnal Insan Farmasi Indonesia (JIFI) is a journal of pharmaceutical science published by Sekolah Tinggi Ilmu Keehatan ISFI Banjarmasin twice a year (May and December). The submitted articles must be unpublished and will be selected by the JIFI editor and reviewer team.

JIFI is an open-access journal (P-ISSN: 2621-3184 & E-ISSN: 2621-4032) which means that all content is freely available without charge to the user. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.

 

Focus and Scope
Jurnal Insan Farmasi Indonesia (JIFI) is a broad-based primary journal covering all branches of pharmacy and its sub-disciplines that contains complete research articles, short communication and review articles. JIFI is a forum for the publication of quality and original works that open discussions in the field of pharmacy and health sciences.

Focus and Scope:
-Pharmaceutics
-Phytochemistry
-Pharmaceutical analysis
-Drug development
-Herbal technology
-Pharmacognosy
-Drug formulation
-Nanotechnology
-Novel drug delivery system
-Pharmacoinformatic
-Bioinformatics
-Synthetic Chemistry

Peer Review Process / Policy
All manuscripts submitted to this journal should follow the focus and scope, and author guidelines of this journal. When a manuscript is submitted, a submission ID number will be given. Always refer to this ID number in communications with the editor. The corresponding author is responsible for informing fellow writers about the status of the manuscript during the review and publication process.

All manuscripts must be free from plagiarism content. All authors are advised to use plagiarism detection software to check the similarity before submitting the draft. The editor checks all manuscripts to see if there are any similarities with other articles. The editor reviews the manuscript for the scope and then sends it to reviewers. All manuscripts are considered to be confidential and undergo a blind review.

All reviewers are expected to complete their reviews after receiving the manuscript. The final decision on article acceptance will be made by the Editors according to the reviewer's comments. The corresponding author is notified of the editorial decision to accept, reject, or require modification.

Open Access Policy
Jurnal Insan Farmasi Indonesia (JIFI) provides direct open access to its content with the principle that making research freely available to the public and supporting greater global knowledge exchange.

All articles published by Open Access will be permanently free for everyone to read and download. We are continuing to work with our author communities to select the best choice of license options: Creative Commons Attribution-ShareAlike (CC BY-SA)

The Authors submitting the manuscript understand that the copyright of the accepted article will be transferred to Jurnal Insan Farmasi Indonesia (JIFI) and Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin as the publisher of the journal.
The article processing charge (APC) is Rp. 300.000,- which is paid after there is a certainty that the submitted manuscript is accepted.

Publication Ethics and Malpractice Statement
Jurnal Insan Farmasi Indonesia (JIFI) established the publication ethics of all parties involved in publishing articles in this journal, including the authors, editor-in-chief, Editorial Board, peer-reviewers and publishers (Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin). The authors, reviewers, and editors are expected to follow the best practice guidelines on ethical behaviour contained therein.

Duties of Editors:

Fair play and editorial independence
Confidentiality
Disclosure and conflicts of interest
Publication decisions
Involvement and cooperation in investigations
Duties of Reviewers

Contribution to editorial decisions
Promptness
Confidentiality
Standards of objectivity
Acknowledgement of sources
Disclosure and conflicts of interest
Duties of Authors

Reporting standards
Data access and retention
Originality and plagiarism
Multiple, duplicate, redundant or concurrent submission/publication
Authorship of the manuscript
Disclosure and conflicts of interest
Acknowledgement of sources
Peer review
Fundamental errors in published works
Duties of the Publisher

Handling of unethical publishing behaviour
Access to journal content
Content Licence
Jurnal Insan Farmasi Indonesia (JIFI) applies Creative Commons Attribution-ShareAlike (CC BY-SA) licenses to all works that we publish. This license was developed to facilitate open access, i.e. free direct access, and unlimited reuse, of original works of all types. Under this license, the authors agree to make articles legally available for reuse, without permission or fees, for almost all purposes. Anyone can copy, distribute or reuse these articles, as long as the author and source are properly cited.

No permission is required from the authors or the publishers to reuse for specific purposes the JIIS content as long as it cites the original article. In most cases, appropriate attribution can be provided by simply citing the original article.

Duties of authors

Reporting standards

Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behaviour and are unacceptable. Review and professional publication articles should also be accurate and objective, and editorial opinion works should be identified as such.

Data access and retention

Authors may be asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data, if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

 

Originality and plagiarism

The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others, that this has been appropriately cited or quoted. Plagiarism takes many forms, from A passing off­ another a­s paper as the author a­s own paper, to copying or paraphrasing substantial parts of another as paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behaviour and is unacceptable. Indonesian Journal of Clinical Pharmacy has aTurnitin Application. Turnitin also offers iThenticate, a plagiarism detection service for commercial markets, and WriteCheck, a suite of formative tools for writers.

 

Multiple, redundant or concurrent publication

An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behaviour and is unacceptable. In general, an author should not submit for consideration in another journal a previously published paper. Publication of some kinds of articles (e.g. clinical guidelines, translations) in more than one journal is sometimes justifiable, provided certain conditions are met. The authors and editors of the journals concerned must agree to the secondary publication, which must reflect the same data and interpretation of the primary document. The primary reference must be cited in the secondary publication.

 

Acknowledgement of sources

Proper acknowledgement of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work. Information obtained privately, as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.

 

Authorship of the paper

Authorship should be limited to those who have contributed significantly to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where others have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included in the paper and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

 

Ethical Approval

We require every research article submitted to JIFI to include a statement that the study obtained ethics approval (or a statement that it was not required), including the name of the ethics committee(s) or institutional review board(s), the number/ID of the approval(s), and a statement that participants gave informed consent before taking part.

 

Disclosure and conflicts of interest

All authors should disclose in their manuscript any financial or other substantive conflicts of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed. Examples of potential conflicts of interest which should be disclosed include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Potential conflicts of interest should be disclosed at the earliest stage possible.

Fundamental errors in published works

When an author discovers a significant error or inaccuracy in their published work, it is the authorís obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper. If the editor or the publisher learns from a third party that a published work contains a significant error, the author must promptly retract or correct the paper or provide evidence to the editor of the correctness of the original paper.

(These guidelines are based on Elsevier policies and COPE's Best Practice Guidelines for Journal Editors)

 

Duties of reviewers

Contribution to editorial decisions

Peer review assists the editor in making editorial decisions and the editorial communications with the author may also assist the author in improving the paper. Peer review is an essential component of formal scholarly communication, and lies at the heart of the scientific method.

Promptness

Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.

Confidentiality

Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.

Standards of objectivity

Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.

Acknowledgement of sources

Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

Disclosure and conflict of interest

Unpublished materials disclosed in a submitted manuscript must not be used in a reviewerís own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

(These guidelines are based on Elsevier policies and COPEís Best Practice Guidelines for Journal Editors).